Stock BMY BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Real-time Estimate Cboe BZX
Other stock markets
 01:39:18 2024-04-19 pm EDT 		5-day change 1st Jan Change
48.74 USD +0.92% Intraday chart for Bristol-Myers Squibb Company +0.86% -5.10%
Apr. 18 Wells Fargo Adjusts Bristol-Myers Squibb's Price Target to $52 From $51, Keeps Equalweight Rating MT
Apr. 17 TORL BioTherapeutics LLC announced that it has received $158.3 million in funding from a group of investors CI

Chart calendar Bristol-Myers Squibb Company

7cbe57eedc1.SqtOTglTteLPshnj7_LtBWH4H8Mv69FU3WBRSGbi06w.P84aNkUM_7iX6nSzvZuXSwWvR5tkm-IV8DU_KzmNtf0O4z53ezzilJnnfg~10d35372b9424f1f5deb6c09db618c10

Upcoming events on Bristol-Myers Squibb Company

2024-04-25 06:59 am Q1 2024 Earnings Release
2024-04-25 08:00 am Q1 2024 Earnings Call
2024-05-07 10:00 am Annual General Meeting
2024-07-26 06:59 am Q2 2024 Earnings Release
2024-07-26 08:00 am Q2 2024 Earnings Call
2024-10-31 06:59 am Q3 2024 Earnings Release
2024-10-31 08:00 am Q3 2024 Earnings Call
2025-02-06 06:59 am Q4 2024 Earnings Release
2025-02-06 08:00 am Q4 2024 Earnings Call
2025-04-25 06:59 am Q1 2025 Earnings Release
2025-04-25 08:00 am Q1 2025 Earnings Call
2025-07-31 06:59 am Q2 2025 Earnings Release
2025-07-31 08:00 am Q2 2025 Earnings Call
2025-10-31 06:59 am Q3 2025 Earnings Release
2025-10-31 08:00 am Q3 2025 Earnings Call

Past events on Bristol-Myers Squibb Company

2024-04-07 01:45 pm American College of Cardiology Scientific Meeting - Poster No 1075-09
2024-04-07 01:30 pm American College of Cardiology Scientific Meeting - Poster No: 1075-07
2024-04-07 01:15 pm American College of Cardiology Scientific Meeting - Abstract No: 1424-134
2024-04-07 12:00 pm American College of Cardiology Scientific Meeting - Poster No: 1065-11
2024-04-06 02:45 pm American College of Cardiology Scientific Meeting - Poster No: 1306-157
2024-04-06 01:45 pm American College of Cardiology Scientific Meeting - Poster No: 1284-132
2024-04-06 11:45 am American College of Cardiology Scientific Meeting - Poster No: 1244-128
2024-04-03 Ex-dividend day
2024-04-02 Schizophrenia International Research Society Congress
2024-03-14 Federal Register Oncologic Drugs Advisory Committee Meeting
2024-03-14 08:30 am Barclays Global Healthcare Conference
2024-03-13 10:00 am Leerink Partners Global Biopharma Conference
2024-03-04 09:50 am TD Cowen Health Care Conference
2024-02-28 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P47
2024-02-28 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P47
2024-02-28 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P35
2024-02-28 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P09
2024-02-28 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P09
2024-02-28 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P35
2024-02-28 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P09

Past dividends on Bristol-Myers Squibb Company

2024-04-03 Quarterly 0.6 USD
2024-01-03 Quarterly 0.6 USD
2023-10-04 Quarterly 0.57 USD
2023-07-05 Quarterly 0.57 USD
2023-04-05 Quarterly 0.57 USD
2023-01-04 Quarterly 0.57 USD
2022-10-05 Quarterly 0.54 USD
2022-06-29 Quarterly 0.54 USD
2022-03-30 Quarterly 0.54 USD
2022-01-05 Quarterly 0.54 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		26 145
26 418
-1.03%		42 518
42 189
0.78%		46 385
46 366
0.04%		46 159
45 911
0.54%		45 006
44 731
0.62%
45 827

EBITDA
Million USD		Released
Forecast
Spread 		9 945
9 754
1.96%		18 118
20 279
-10.65%		20 493
21 878
-6.33%		20 123
20 368
-1.2%		17 498
18 255
-4.15%
4 607

EBIT
Million USD		Released
Forecast
Spread 		8 199
8 540
-3.99%		17 426
17 664
-1.35%		19 830
19 963
-0.67%		19 442
18 924
2.73%		16 785
16 921
-0.8%
3 979

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		4 975
0,00
- 		-6 871
1 541
-545.88%		8 098
7 644
5.94%		7 713
7 912
-2.51%		8 440
8 846
-4.59%
-18 524

Net income
Million USD		Released
Forecast
Spread 		3 439
0,00
- 		-9 015
1 269
-810.58%		6 994
6 219
12.46%		6 327
6 617
-4.39%		8 025
7 823
2.58%
-3 954

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		-3,99
0,53
-851.84%		3,12
2,78
12.07%		2,95
2,97
-0.55%		3,86
3,73
3.53%
-1,45

Announcement Date06/02/2004/02/2104/02/2202/02/2302/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		11 985
11 998
-0.11%		11 648
11 343
2.69%		11 887
11 467
3.66%		11 218
11 180
0.34%		11 406
11 198
1.86%		11 337
11 498
-1.4%		11 226
11 811
-4.95%		10 966
10 959
0.06%		11 477
11 203
2.45%
11 454


11 521


11 274


11 730


11 694

EBITDA
Million USD		Released
Forecast
Spread 		4 832
5 087
-5.01%		5 305
5 176
2.5%		7 812
5 060
54.38%		7 424
4 973
49.29%		4 288
4 594
-6.66%		5 030
4 732
6.3%		4 268
6 031
-29.24%		4 539
5 339
-14.98%		3 816
4 833
-21.04%
-8 519


4 549


4 218


4 368




EBIT
Million USD		Released
Forecast
Spread 		4 670
4 823
-3.17%		5 267
4 848
8.63%		5 229
4 563
14.58%		4 836
4 622
4.62%		4 110
4 248
-3.26%		4 857
4 816
0.85%		4 251
4 785
-11.16%		4 360
4 206
3.66%		3 630
3 663
-0.91%
-8 507


4 268


4 186


4 220


4 957

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread





1 958
2 118
-7.55%		2 209
2 139
3.27%		1 859
1 767
5.21%		2 770
2 808
-1.34%		1 859
2 836
-34.44%		2 137
2 216
-3.58%		1 674
2 000
-16.28%



2 302


2 226


2 268




Net income
Million USD		Released
Forecast
Spread 		2 372
1 419
67.16%		1 278


1 421
1 423
-0.11%		1 606
1 469
9.33%		2 022
1 444
40.03%		2 262
2 290
-1.24%		2 073
2 165
-4.23%		1 928
1 585
21.63%		1 762
1 479
19.13%
-9 816


1 860


1 761


1 953




EPS
USD		Released
Forecast
Spread 		1,07
0,96
11.85%		0,59
0,86
-31.4%		0,66
0,58
13.79%		0,75
0,71
5.63%		0,95
0,73
31.03%		1,07
1,19
-10.08%		0,99
1,16
-14.88%		0,93
0,89
4.03%		0,87
0,72
20.52%
-4,68


1,03


0,98


1,06


1,83

Announcement Date04/02/2229/04/2227/07/2225/10/2202/02/2327/04/2327/07/2326/10/2302/02/24-----

Upcoming sector events for Bristol-Myers Squibb Company

2024-04-19 TEYI PHARMACEUTICAL GROUP CO.,LTD: Q1 2024 Earnings Release
2024-04-19 FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-19 ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release
2024-04-19 HUNAN WARRANT PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
2024-04-19 HAISCO PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release
2024-04-19 CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-19 JIANGSU NHWA PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
2024-04-19 CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.: Q1 2024 Earnings Release
2024-04-19 ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD: Q1 2024 Earnings Release
2024-04-19 HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
More events

Past sector events for Bristol-Myers Squibb Company

Today TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD: Q4 2023 Earnings Release
Today BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.: Q4 2023 Earnings Release
Today ZHEJIANG WOLWO BIO-PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today ZHEJIANG WOLWO BIO-PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today JINGHUA PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release
Today GUIZHOU YIBAI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today GUIZHOU YIBAI PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release
2024-04-17 SHANDONG WIT DYNE HEALTH CO.,LTD.: Q1 2024 Earnings Release
2024-04-17 APELOA PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BMY Stock
  4. Calendar Bristol-Myers Squibb Company